Tumor infiltrating lymphocytes (TIL)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor infiltrating lymphocytes (TIL), covering 2025-07-03 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors [Phase 1]